Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Balance Sheet

MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Balance Sheet History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
EQUITY AND LIABILITIES
Share Capital ₹41 Cr₹41 Cr₹40 Cr₹40 Cr₹40 Cr
    Equity - Authorised ₹228 Cr₹228 Cr₹209 Cr₹41 Cr₹41 Cr
    Equity - Issued ₹41 Cr₹41 Cr₹40 Cr₹40 Cr₹40 Cr
    Equity Paid Up ₹41 Cr₹41 Cr₹40 Cr₹40 Cr₹40 Cr
    Equity Shares Forfeited -----
    Adjustments to Equity -----
    Preference Capital Paid Up -----
    Face Value ₹1.00₹1.00₹1.00₹1.00₹1.00
Share Warrants & Outstandings ₹48 Cr₹44 Cr₹23 Cr₹0.06 Cr-
Total Reserves ₹16,211 Cr₹14,247 Cr₹9,300 Cr₹7,395 Cr₹6,115 Cr
    Securities Premium ₹3,043 Cr₹3,008 Cr₹42 Cr₹42 Cr₹42 Cr
    Capital Reserves ₹-909 Cr₹-909 Cr₹-909 Cr₹-909 Cr₹-909 Cr
    Profit & Loss Account Balance ₹13,804 Cr₹11,907 Cr₹9,919 Cr₹8,012 Cr₹6,735 Cr
    General Reserves ₹238 Cr₹238 Cr₹238 Cr₹238 Cr₹238 Cr
    Other Reserves ₹35 Cr₹3.84 Cr₹10 Cr₹12 Cr₹9.11 Cr
Reserve excluding Revaluation Reserve ₹16,211 Cr₹14,247 Cr₹9,300 Cr₹7,395 Cr₹6,115 Cr
Revaluation reserve -----
Shareholder's Funds ₹16,300 Cr₹14,332 Cr₹9,363 Cr₹7,435 Cr₹6,155 Cr
Minority Interest ₹261 Cr₹236 Cr₹213 Cr₹188 Cr₹161 Cr
Long-Term Borrowings -----
Secured Loans ₹2,483 Cr₹5,078 Cr₹25 Cr₹23 Cr₹49 Cr
    Non Convertible Debentures ₹4,971 Cr₹4,943 Cr---
    Converible Debentures & Bonds -----
    Packing Credit - Bank -----
    Inter Corporate & Security Deposit -----
    Term Loans - Banks ₹74 Cr₹396 Cr₹43 Cr₹45 Cr₹67 Cr
    Term Loans - Institutions -----
    Other Secured ₹-2,561 Cr₹-261 Cr₹-19 Cr₹-22 Cr₹-18 Cr
Unsecured Loans ₹339 Cr₹448 Cr--₹0.25 Cr
    Fixed Deposits - Public -----
    Loans and advances from subsidiaries -----
    Inter Corporate Deposits (Unsecured) -----
    Foreign Currency Convertible Notes -----
    Long Term Loan in Foreign Currency -----
    Loans - Banks -₹131 Cr---
    Loans - Govt. -----
    Loans - Others ₹339 Cr₹317 Cr--₹0.25 Cr
    Other Unsecured Loan -----
Deferred Tax Assets / Liabilities ₹1,515 Cr₹1,705 Cr₹8.68 Cr₹48 Cr₹16 Cr
    Deferred Tax Assets ₹735 Cr₹728 Cr₹454 Cr₹315 Cr₹228 Cr
    Deferred Tax Liability ₹2,250 Cr₹2,432 Cr₹463 Cr₹362 Cr₹244 Cr
Other Long Term Liabilities ₹101 Cr₹34 Cr₹31 Cr₹31 Cr₹23 Cr
Long Term Trade Payables -----
Long Term Provisions ₹249 Cr₹155 Cr₹123 Cr₹98 Cr₹80 Cr
Total Non-Current Liabilities ₹4,687 Cr₹7,420 Cr₹187 Cr₹199 Cr₹169 Cr
Current Liabilities -----
Trade Payables ₹1,341 Cr₹1,133 Cr₹777 Cr₹1,008 Cr₹1,076 Cr
    Sundry Creditors ₹1,341 Cr₹1,133 Cr₹777 Cr₹1,008 Cr₹1,076 Cr
    Acceptances -----
    Due to Subsidiaries- Trade Payables -----
Other Current Liabilities ₹3,702 Cr₹1,335 Cr₹756 Cr₹386 Cr₹473 Cr
    Bank Overdraft / Short term credit ----₹11 Cr
    Advances received from customers ₹28 Cr₹33 Cr₹27 Cr₹26 Cr₹17 Cr
    Interest Accrued But Not Due ₹183 Cr₹183 Cr---
    Share Application Money -----
    Current maturity of Debentures & Bonds -----
    Current maturity - Others -----
    Other Liabilities ₹3,491 Cr₹1,120 Cr₹728 Cr₹360 Cr₹446 Cr
Short Term Borrowings ₹639 Cr₹2,513 Cr₹151 Cr₹115 Cr₹795 Cr
    Secured ST Loans repayable on Demands ₹538 Cr₹505 Cr₹151 Cr₹115 Cr₹731 Cr
    Working Capital Loans- Sec ₹538 Cr₹497 Cr₹151 Cr₹115 Cr₹731 Cr
    Buyers Credits - Unsec -----
    Commercial Borrowings- Unsec -----
    Other Unsecured Loans ₹-437 Cr₹1,512 Cr₹-151 Cr₹-115 Cr₹-668 Cr
Short Term Provisions ₹825 Cr₹682 Cr₹436 Cr₹354 Cr₹280 Cr
    Proposed Equity Dividend -----
    Provision for Corporate Dividend Tax -----
    Provision for Tax ₹11 Cr₹18 Cr₹8.38 Cr₹46 Cr₹15 Cr
    Provision for post retirement benefits -----
    Preference Dividend -----
    Other Provisions ₹814 Cr₹664 Cr₹427 Cr₹308 Cr₹265 Cr
Total Current Liabilities ₹6,507 Cr₹5,664 Cr₹2,120 Cr₹1,863 Cr₹2,623 Cr
Total Liabilities ₹27,755 Cr₹27,652 Cr₹11,883 Cr₹9,686 Cr₹9,108 Cr
ASSETS
Gross Block ₹21,377 Cr₹20,917 Cr₹5,910 Cr₹5,233 Cr₹4,247 Cr
Less: Accumulated Depreciation ₹2,756 Cr₹1,912 Cr₹1,370 Cr₹988 Cr₹664 Cr
Less: Impairment of Assets -----
Net Block ₹18,620 Cr₹19,004 Cr₹4,540 Cr₹4,245 Cr₹3,583 Cr
Lease Adjustment A/c -----
Capital Work in Progress ₹655 Cr₹306 Cr₹207 Cr₹493 Cr₹670 Cr
Non Current Investments ₹448 Cr₹351 Cr₹310 Cr₹271 Cr₹235 Cr
Long Term Investment ₹448 Cr₹351 Cr₹310 Cr₹271 Cr₹235 Cr
    Quoted -----
    Unquoted ₹509 Cr₹411 Cr₹364 Cr₹325 Cr₹285 Cr
Long Term Loans & Advances ₹555 Cr₹293 Cr₹164 Cr₹188 Cr₹164 Cr
Other Non Current Assets ₹50 Cr₹189 Cr₹14 Cr₹99 Cr₹13 Cr
Total Non-Current Assets ₹20,801 Cr₹20,663 Cr₹5,315 Cr₹5,358 Cr₹4,702 Cr
Current Assets Loans & Advances -----
Currents Investments ₹1,537 Cr₹1,691 Cr₹2,258 Cr₹1,075 Cr₹874 Cr
    Quoted ₹1,537 Cr₹1,691 Cr₹2,258 Cr₹1,075 Cr₹874 Cr
    Unquoted -----
Inventories ₹2,144 Cr₹2,094 Cr₹1,553 Cr₹1,498 Cr₹1,760 Cr
    Raw Materials ₹629 Cr₹552 Cr₹409 Cr₹414 Cr₹399 Cr
    Work-in Progress ₹223 Cr₹186 Cr₹100 Cr₹86 Cr₹94 Cr
    Finished Goods ₹288 Cr₹300 Cr₹263 Cr₹285 Cr₹310 Cr
    Packing Materials -----
    Stores  and Spare ₹55 Cr₹46 Cr₹44 Cr₹35 Cr₹24 Cr
    Other Inventory ₹950 Cr₹1,010 Cr₹738 Cr₹678 Cr₹934 Cr
Sundry Debtors ₹1,730 Cr₹1,538 Cr₹848 Cr₹576 Cr₹388 Cr
    Debtors more than Six months ₹75 Cr₹68 Cr₹44 Cr₹21 Cr₹15 Cr
    Debtors Others ₹1,716 Cr₹1,531 Cr₹832 Cr₹575 Cr₹385 Cr
Cash and Bank ₹483 Cr₹555 Cr₹708 Cr₹453 Cr₹406 Cr
    Cash in hand ₹0.68 Cr₹0.55 Cr₹0.74 Cr₹0.46 Cr₹0.25 Cr
    Balances at Bank ₹482 Cr₹554 Cr₹707 Cr₹453 Cr₹403 Cr
    Other cash and bank balances ----₹2.29 Cr
Other Current Assets ₹101 Cr₹97 Cr₹104 Cr₹64 Cr₹171 Cr
    Interest accrued on Investments -----
    Interest accrued on Debentures -----
    Deposits with Government -----
    Interest accrued and or due on loans -----
    Prepaid Expenses ₹52 Cr₹61 Cr₹60 Cr₹33 Cr₹136 Cr
    Other current_assets ₹49 Cr₹36 Cr₹44 Cr₹31 Cr₹35 Cr
Short Term Loans and Advances ₹957 Cr₹1,011 Cr₹1,093 Cr₹657 Cr₹804 Cr
    Advances recoverable in cash or in kind ₹124 Cr₹91 Cr₹42 Cr₹77 Cr₹73 Cr
    Advance income tax and TDS -----
    Amounts due from directors -----
    Due From Subsidiaries -----
    Inter corporate deposits -----
    Corporate Deposits -----
    Other Loans & Advances ₹833 Cr₹919 Cr₹1,052 Cr₹580 Cr₹731 Cr
Total Current Assets ₹6,952 Cr₹6,986 Cr₹6,566 Cr₹4,325 Cr₹4,404 Cr
Net Current Assets (Including Current Investments) ₹444 Cr₹1,322 Cr₹4,446 Cr₹2,461 Cr₹1,780 Cr
Miscellaneous Expenses not written off -----
Total Assets ₹27,755 Cr₹27,652 Cr₹11,883 Cr₹9,686 Cr₹9,108 Cr
Contingent Liabilities ₹925 Cr₹1,019 Cr₹89 Cr₹48 Cr₹83 Cr
Total Debt ₹6,022 Cr₹8,300 Cr₹196 Cr₹163 Cr₹868 Cr
Book Value 393.72346.31233.15185.61153.65
Adjusted Book Value 393.72346.31233.15185.61153.65

Compare Balance Sheet of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹97,963.6 Cr -1.2% -7.2% -3.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,090.0 Cr 1% -2.7% 15.7% Stock Analytics
DIVIS LABORATORIES ₹226,976.0 Cr 0.7% 17.1% 40.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,639.0 Cr -0.3% -3.7% 37.9% Stock Analytics
CIPLA ₹115,216.0 Cr -0.3% 2.3% -8.1% Stock Analytics
DR REDDYS LABORATORIES ₹98,074.4 Cr -1.4% 0.7% -6.2% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-1.2%

-7.2%

-3.5%

SENSEX

-0.6%

1%

-3.7%


You may also like the below Video Courses